Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Timing of Vaccination Impacts Serological Response to COVID-19 Myeloma Patients after BCMA-Targeted CAR T

Blood (2023) 142 (Supplement 1): 3350.

https://doi.org/10.1182/blood-2023-184409

Published: 2023

Journal Articles

Cellular Mechanisms Associated with Suboptimal Immune Responses to Sars-Cov-2 Bivalent Booster Vaccination in Patients with Multiple Myeloma

Adolfo Aleman, Morgan Van Kesteren, Ariel Kogan Zajdman, Komal Srivastava, Lucia Y Chen, Bhaskar Upadhyaya, Jessica Nardulli, Kseniya Serebryakova, Katerina Kappes, Hayley Jackson, Charles Gleason, Oliver Van Oekelen, Carlos Cordon-Cardo, Ania Wajnberg, Florian Krammer, Miriam Merad, Sundar Jagannath, Viviana Simon, Samir Parekh

Blood (2023) 142 (Supplement 1): 1984.

https://doi.org/10.1182/blood-2023-187260

Published: 2023

Journal Articles

Cellular Immune Composition in Multiple Myeloma Patients Associated with Variable Humoral Responses to Sars-Cov-2 Vaccination

Ariel Kogan Zajdman, Adolfo Aleman, Bhaskar Upadhyaya, Katherine F. Beach, Kseniya Serebryakova, Sarita Agte, Katerina Kappes, Charles R. Gleason, Komal Srivastava, Oliver Van Oekelen, Carlos Cordon-Cardo, Florian Krammer, Miriam Merad, Sundar Jagannath, Ania Wajnberg, Viviana Simon, Samir Parekh

Blood (2022) 140 (Supplement 1): 4364–4365.

https://doi.org/10.1182/blood-2022-169572

Published: 2022

Journal Articles

Suboptimal Humoral and Cellular Immune Response to SARS-CoV-2 RNA Vaccination in Myeloma Patients Is Associated with Anti-CD38 and BCMA-Targeted Treatment

Blood (2021) 138 (Supplement 1): 822.

https://doi.org/10.1182/blood-2021-152365

Published: 2021

Journal Articles

N-Me, a Long Range T-Cell Specific Oncogenic Enhancer in T-ALL

Daniel Herranz, PhD, Alberto Ambesi-Impiombato, MD PhD, Teresa Palomero, PhD, Stephanie A. Schnell, Laura Belver, PhD, Agnieszka A. Wendorff, PhD, Luyao Xu, Mireia Castillo-Martin, MD, David Llobet-Navas, PhD, Carlos Cordon-Cardo, MD PhD, Emmanuelle Clappier, Jean Soulier, MD PhD, Adolfo A. Ferrando, MD PhD

Blood (2014) 124 (21): 487.

https://doi.org/10.1182/blood.V124.21.487.487

Published: 2014

Journal Articles

Therapeutic Utility of PI3Kγ Inhibition in Leukemogenesis and Tumor Cell Survival

Thomas Diacovo, MD, Dosh Whye, Evgeni Efimenko, Jianchung Chen, Valeria Tosello, PhD, Kim De Keersmaecker, PhD, Adam Kashishian, Mary Ann Thompson, MD, PhD, Mireia Castillo, MD, Carlos Cordon-Cardo, MD, PhD, Utpal P. Dave, MD, Adolfo A. Ferrando, MD, PhD, Brian J. Lannutti, PhD, Prem Subramaniam

Blood (2012) 120 (21): 1492.

https://doi.org/10.1182/blood.V120.21.1492.1492

Published: 2012

Journal Articles

An Oncogenic Metabolic Switch Mediates Resistance to NOTCH1 Inhibition in T-ALL

Daniel Herranz, PhD, Valeria Tosello, PhD, Alberto Ambesi-Impiombato, MD, PhD, Mireia Castillo, MD, Carlos Cordon-Cardo, MD, PhD, Adolfo A. Ferrando, MD, PhD

Blood (2012) 120 (21): 285.

https://doi.org/10.1182/blood.V120.21.285.285

Published: 2012

Journal Articles

BCL11B Mutations In T-Cell Acute Lymphoblastic Leukemia

Blood (2010) 116 (21): 471.

https://doi.org/10.1182/blood.V116.21.471.471

Published: 2010

Journal Articles

The HOX11/TLX1 Transcription Factor Oncogene Induces Chromosomal Aneuploidy in T-ALL.

Kim De Keersmaecker, PhD, Pedro Jose Real Luna, PhD, Giusy Della Gatta, PhD, Teresa Palomero, PhD, Mireia Castillo, MD, Maria Luisa Sulis, MD, Valeria Tosello, PhD, Fotini Gounari, PhD, Barbara Kee, PhD, Jack Lenz, PhD, Michelle Kelliher, PhD, Peter D. Aplan, MD, Carlos Cordon-Cardo, MD, PhD, Adolfo A. Ferrando, MD, PhD

Blood (2009) 114 (22): 142.

https://doi.org/10.1182/blood.V114.22.142.142

Published: 2009

Journal Articles

Inhibition of NOTCH1 Signaling and Glucocorticoid Therapy in T-ALL

Pedro Jose Real, PhD, Valeria Tosello, PhD, Teresa Palomero, PhD, Mireia Castillo, MD, Catherine Sawai, Maria Luisa Sulis, MD, Jules P.P. Meijerink, Giuseppe Basso, MD, Iannis Aifantis, PhD, MSC, Carlos Cordon-Cardo, MD, Adolfo A. Ferrando, MD, PhD

Blood (2008) 112 (11): 298.

https://doi.org/10.1182/blood.V112.11.298.298

Published: 2008

Journal Articles

Inhibition of NOTCH1 Signaling Reverses Glucocorticoid Resistance in T-ALL.

Pedro J. Real, PhD, Valeria Tosello, PhD, Walden Ai, PhD, Teresa Palomero, PhD, Maria Luisa Sulis, PhD, Mireia Castillo, MD, Irene Homminga, PhD, Jules Meijerink, PhD, Carlos Cordon-Cardo, MD, PhD, Adolfo Ferrando, MD, PhD

Blood (2007) 110 (11): 151.

https://doi.org/10.1182/blood.V110.11.151.151

Published: 2007

Journal Articles

Critical Role of Dok-1 and Dok-2 in Leukemia Suppression.

Masaru Niki, M.D., Ph.D., Antonio Di Cristofano, Ph.D., Mingming Zhao, Ph.D., Hisamaru Hirai, M.D., Linda Van Aelst, Ph.D., Carlos Cordon-Cardo, M.D., Ph.D., Pier Paolo Pandolfi, M.D., Ph.D.

Blood (2004) 104 (11): 2951.

https://doi.org/10.1182/blood.V104.11.2951.2951

Published: 2004

Journal Articles

Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia

Carmela Gurrieri, Khedoudja Nafa, Taha Merghoub, Rosa Bernardi, Paola Capodieci, Andrea Biondi, Stephen Nimer, Dan Douer, Carlos Cordon-Cardo, Robert Gallagher, Pier Paolo Pandolfi

Blood (2004) 103 (6): 2358–2362.

https://doi.org/10.1182/blood-2003-07-2200

Published: 2004

Journal Articles

Expression of Granulocyte-Macrophage Colony-Stimulating Factor Receptors in Human Prostate Cancer

Coralia I. Rivas, Juan Carlos Vera, Fernando Delgado-López, Mark L. Heaney, Victor H. Guaiquil, Rong H. Zhang, Howard I. Scher, Ilona I. Concha, Francisco Nualart, Carlos Cordon-Cardo, David W. Golde

Blood (1998) 91 (3): 1037–1043.

https://doi.org/10.1182/blood.V91.3.1037

Published: 1998

NARROW

Timing of Vaccination Impacts Serological Response to COVID-19 Myeloma Patients after BCMA-Targeted CAR T

Cellular Mechanisms Associated with Suboptimal Immune Responses to Sars-Cov-2 Bivalent Booster Vaccination in Patients with Multiple Myeloma

Cellular Immune Composition in Multiple Myeloma Patients Associated with Variable Humoral Responses to Sars-Cov-2 Vaccination

Suboptimal Humoral and Cellular Immune Response to SARS-CoV-2 RNA Vaccination in Myeloma Patients Is Associated with Anti-CD38 and BCMA-Targeted Treatment

N-Me, a Long Range T-Cell Specific Oncogenic Enhancer in T-ALL

Therapeutic Utility of PI3Kγ Inhibition in Leukemogenesis and Tumor Cell Survival

An Oncogenic Metabolic Switch Mediates Resistance to NOTCH1 Inhibition in T-ALL

BCL11B Mutations In T-Cell Acute Lymphoblastic Leukemia

The HOX11/TLX1 Transcription Factor Oncogene Induces Chromosomal Aneuploidy in T-ALL.

Inhibition of NOTCH1 Signaling and Glucocorticoid Therapy in T-ALL

Inhibition of NOTCH1 Signaling Reverses Glucocorticoid Resistance in T-ALL.

Critical Role of Dok-1 and Dok-2 in Leukemia Suppression.

Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia

Expression of Granulocyte-Macrophage Colony-Stimulating Factor Receptors in Human Prostate Cancer

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only